Clinical trial
Caffeine in the Prevention of Post-operative Nausea and Vomiting
NCT00130026 · Beth Israel Deaconess Medical Center, Other · Completed
Key facts
| NCT number | NCT00130026 |
|---|---|
| Title | Caffeine in the Prevention of Post-operative Nausea and Vomiting |
| Official title | A Prospective, Randomized, Double-blind, Placebo-controlled Study of Caffeine in the Prevention of Post-operative Nausea and Vomiting in Patients Undergoing Ambulatory Surgery Under General Anesthesia |
| Lead sponsor | Beth Israel Deaconess Medical Center, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Postoperative Nausea and Vomiting |
| Intervention type | Drug |
| Interventions | Caffeine |
| Enrollment | 135 |
| Start date | Mar 1, 2005 |
| Primary completion | Oct 1, 2005 |
| Completion | Oct 1, 2005 |
| First posted | Aug 15, 2005 |
| Last update posted | Feb 7, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: